Moleculin Biotech (MBRX) Stock Price, Quote, News & History | Benzinga

Moleculin Biotech Inc (MBRX) Stock Price, Quote, News & History

MBRXNASDAQ

Trade with Public

Trade with Public

$0.6010

-0.0091-1.49%

Last update: Aug 19, 9:28 AM

Earnings: Q2 2026 Earnings were released on Fri Aug 14th, before the market open

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$0.61

Close

-

Volume / Avg.

92.49K / 1.17M

Day Range

$0.59 - $0.61

52 Wk Range

0.16 - 17.23

Market Cap

$11.71M

P/E Ratio

0.04

Dividend Yield

-

Exchange

NASDAQ

RSI

27

Short Interest

8.12%

Days to Cover

1

Recent Moleculin Biotech Inc News

Moleculin Biotech Stock Is Sinking Friday: What's Going On?

Moleculin Biotech updates MIRACLE trial for AML and prices a $9.3M offering at $0.75, driving MBRX shares down 63%. Read full data.

Vandana Singh

Why is Moleculin Stock Falling Today?

Moleculin reports interim Phase 2/3 trial data as Annamycin shows higher remission rates than control in relapsed or refractory acute myeloid leukemia

Vandana Singh

Nano-Cap Moleculin Biotech Approaches Key Leukemia Trial Data Unblinding

Moleculin Biotech nears first MIRACLE trial data unblinding as Annamycin shows higher remission rates in relapsed AML patients.

Vandana Singh

Crude Oil Gains 2%; Walmart Posts Upbeat Earnings

Avi Kapoor

Dow Falls Over 250 Points; US Initial Jobless Claims Decline

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-25.36M

Investing Cash Flow (TTM)

0

Financing Cash Flow (TTM)

25.09M

Free Cash Flow (TTM)

-25.36M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-270.00K

Analyst Trends and Forecast

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$4.74M

PE Ratio (TTM)

0.04

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.01

Earnings Yield % (TTM)

2427.62%

Earnings Yield % (FWD)

-976.71%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.59

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$7.26M

Debt to Equity

0.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$0.61

Close

-

Volume / Avg.

92.49K / 1.17M

Day Range

$0.59 - $0.61

52 Wk Range

0.16 - 17.23

Market Cap

$11.71M

P/E Ratio

0.04

Dividend Yield

-

Exchange

NASDAQ

RSI

27

Short Interest

8.12%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cance...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Moleculin Biotech (MBRX) stock?

A

You can purchase shares of Moleculin Biotech (NASDAQ:MBRX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Moleculin Biotech (MBRX) competitors?

A

Other companies in Moleculin Biotech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Moleculin Biotech (MBRX) stock?

A

Moleculin Biotech has a consensus price target of $15.60.

Q

What is the current price for Moleculin Biotech (MBRX)?

A

The stock price for Moleculin Biotech (NASDAQ: MBRX) is $0.601 last updated August 19, 2026 at 9:28 AM EDT.

Q

Does Moleculin Biotech (MBRX) pay a dividend?

A

There are no upcoming dividends for Moleculin Biotech.

Q

When is Moleculin Biotech (NASDAQ:MBRX) reporting earnings?

A

Moleculin Biotech does not have any upcoming earnings scheduled.

Q

Is Moleculin Biotech (MBRX) going to split?

A

There is no upcoming split for Moleculin Biotech.

Q

What sector and industry does Moleculin Biotech (MBRX) operate in?

A

Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.